Probiotic Intervention in Constipation
ConditionGastrointestinal Function
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorWecare Probiotics Co., Ltd.
About this trial
To evaluate the effects of probiotic intervention on gastrointestinal function in patients with constipation after 4 weeks of treatment, and to explore its potential effects on immune status and bone metabolism.
Eligibility criteria
Qualifiers
Aged 18-65 years.
Patients with constipation, defined as fewer than three bowel movements per week and/or Bristol Stool Form Scale (BSFS) types 1-2.
Able to comply with the study protocol and complete the study procedures.
Participants who have voluntarily signed the informed consent form.
Disqualifiers
Individuals who have recently taken products with similar functions to the investigational product that may affect the evaluation of study outcomes.
Participants who plan to change their dietary habits during the study period.
Patients with severe allergies or immunodeficiency.
Women who are pregnant, breastfeeding, or planning to become pregnant.
Trial design
Treatments tested in this trial
- GUT99 1
- Placebo
- GUT99 2
Treatment groups
30 Participants
are divided into 3 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov